Search

Displaying results 9591 - 9600 of 10000 in total
  1. Drug

    MBL-HCV1

    go.drugbank.com/drugs/DB17776
    Investigational

    MBL-HCV1 is a monoclonal antibody developed to prevent the recurrence of hepatitis C virus (HCV) in patients receiving a liver transplant.

  2. Drug

    Sevuparin

    go.drugbank.com/drugs/DB15007
    Investigational

    Sevuparin is under investigation in clinical trial NCT03853421 (Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin).

  3. Drug

    Thioglycolic acid

    go.drugbank.com/drugs/DB15429
    Investigational

    Thioglycolic acid is under investigation in clinical trial NCT03238105 (Treatment of Periorbicular Hyperchromia Comparing 10% Thioglycolic Acid Peeling Versus Pulsed Intense Light).

  4. Drug

    Valomaciclovir stearate

    go.drugbank.com/drugs/DB15651
    Investigational

    Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster).

  5. Drug

    Melarsoprol

    go.drugbank.com/drugs/DB12864
    Investigational

    Melarsoprol is under investigation in clinical trial NCT00330148 (Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis).

  6. Drug

    Anzurstobart

    go.drugbank.com/drugs/DB17547
    Investigational

    It is being investigated for cancers. … Anzurstobart is a monoclonal antibody directed against signal-regulatory protein alpha (SIRPα) on monocytes and macrophages to potently block the CD47-SIRPα interaction.

  7. Drug

    Enviomycin

    go.drugbank.com/drugs/DB08993
    Experimental

    It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.

    Synonyms: Tuberactinomycin N
  8. Drug

    Actinium Ac 225 dotatate

    go.drugbank.com/drugs/DB23632
    Investigational

    Actinium Ac 225 dotatate is under investigation in clinical trial NCT07150806 (RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma). … Actinium Ac 225 dotatate is a biologic drug.

  9. Drug

    FT-1101

    go.drugbank.com/drugs/DB17553
    Investigational

    [A257301] FT-1101 is under investigation in clinical trial NCT02543879 (Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies). … FT-1101 is a novel Bromodomain and Extra-Terminal motif (BET) inhibitor.

  10. Drug

    Inaxaplin

    go.drugbank.com/drugs/DB21521
    Investigational

    Inaxaplin is under investigation in clinical trial NCT06794996 (Phase 2b Open-label Study of Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease). … Inaxaplin is a small molecule drug.